keepin the faith. The new management seems to be on the ball. Regulators can be very tough---especially if a company has no track record. My bet is they continue to work through paperwork. Remember, there is no data or efficacy tied to Mark approval. The process is all about documentation.
and another week of crmd "trading" begins. Most options trade more volume than this stock.
Maybe they got the CE Mark already but are working on a deal with Tauropharm. Then they'll put out 1 press release and say "got the CE Mark, expect revenues for 2013 in the $50M range" and then the stock will go to $20.